Tag: Novel treatments

With approximately 21 million adults in the U.S. experiencing at least one major depressive episode, the search for new treatments is constant [1.3.1]. So, what are the upcoming psychiatric drugs for 2025? The pipeline includes novel mechanisms and reformulations offering new hope.

Recent research indicates that schizophrenia spectrum disorders are more common than previously thought, affecting approximately 1.8% of U.S. adults [1.8.1]. For them, the critical question is often, **what is the new drug for schizophrenia?** The latest answer marks a significant breakthrough in treatment.